The price of Corebridge Financial Inc. (NYSE: CRBG) closed at $16.39 in the last session, down -4.93% from day before closing price of $17.24. In other words, the price has decreased by -$0.85 from its previous closing price. On the day, 2436115 shares were traded. CRBG stock price reached its highest trading level at $16.76 during the session, while it also had its lowest trading level at $15.95.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
We take a closer look at CRBG’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.92 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.60. In the meantime, Its Debt-to-Equity ratio is 2.04 whereas as Long-Term Debt/Eq ratio is at 1.84.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Credit Suisse on January 13, 2023, Downgraded its rating to Neutral and sets its target price to $23 from $26 previously.
On October 11, 2022, Citigroup started tracking the stock assigning a Neutral rating and target price of $23.
On October 10, 2022, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $23.Wells Fargo initiated its Overweight rating on October 10, 2022, with a $23 target price.
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 10 when Colberg Alan B. bought 30,000 shares for $22.92 per share. The transaction valued at 687,474 led to the insider holds 37,858 shares of the business.
As of this moment, Corebridge’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.89, and their Forward P/E ratio for the next fiscal year is 3.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 1.40.
Stock Price History:
Over the past 52 weeks, CRBG has reached a high of $23.50, while it has fallen to a 52-week low of $16.71. The 50-Day Moving Average of the stock is 20.54, while the 200-Day Moving Average is calculated to be 20.84.
According to the various share statistics, CRBG traded on average about 1.71M shares per day over the past 3-months and 2.12M shares per day over the past 10 days. A total of 645.00M shares are outstanding, with a floating share count of 141.83M. Insiders hold about 78.00% of the company’s shares, while institutions hold 22.70% stake in the company. Shares short for CRBG as of Jan 30, 2023 were 6.32M with a Short Ratio of 5.43M, compared to 6.76M on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.98% and a Short% of Float of 4.40%.
The company has 13 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0.85, with high estimates of $0.91 and low estimates of $0.78.
Analysts are recommending an EPS of between $2.78 and $2.64 for the fiscal current year, implying an average EPS of $2.69. EPS for the following year is $3.71, with 13 analysts recommending between $3.84 and $3.5.
Based on 5 analysts’ estimates, the company’s revenue will be $19.22B in the next fiscal year. The high estimate is $19.61B and the low estimate is $18.53B. The average revenue growth estimate for next year is up 7.10% from the average revenue estimate for this year.